Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    0.00 (0.00%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Grant Awards

17 Nov 2015 07:00

RNS Number : 8974F
Haydale Graphene Industries PLC
17 November 2015
 

 

Haydale Graphene Industries plc

 

("Haydale", the "Group" or the "Company")

 

Patent Grant in Australia

 

Haydale Graphene Industries plc (AIM: HAYD), the Group focused on enabling technology for the commercialisation of graphene and other nano materials, is pleased to announce receipt of the Certificate of Grant from the Patent Office of the Commonwealth of Australia. This grant relates to the key process patent underlying the Company's proprietary functionalisation treatment and is one of a number arising from the families of patent applications surrounding the Haydale plasma process.

 

Furthermore, as announced on 14 October 2015, the European Patent Office (EPO) duly granted the European patent to Haydale on 4 November 2015 and the Company has now received the Certificate of Grant from the EPO in respect of this grant.

 

Ray Gibbs, CEO at Haydale, commented:

 

"As with the earlier grant by the EPO, the patent award in Australia covers all nano particles, not just graphene, which provides Haydale with the protection to develop an extended range of nano materials. I am pleased that we now have our IP protected in China, Australia and Europe. Part of our strategy for growth is the continual development of our technology and the protection of this IP through patent applications. I look forward to being able to announce further patent awards in other territories in due course."

 

- Ends -

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman

David Banks

Will Goode

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphenes and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is an enabling technology, allowing the Company to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

www.haydale.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKADKABDDFDD
Date   Source Headline
19th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 201911:19 amRNSResult of General Meeting
12th Mar 20197:00 amRNSResult of Open Offer
1st Mar 201912:04 pmRNSHolding(s) in Company
27th Feb 20192:00 pmRNSPrice Monitoring Extension
26th Feb 20191:34 pmRNSHolding(s) in Company
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Feb 201912:54 pmRNSResult of Placing and Subscription
22nd Feb 201911:05 amRNSSecond Price Monitoring Extn
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Jan 20197:00 amRNSHolding(s) in Company
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing
8th Aug 20183:01 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.